Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov page.
    Difference
    0.2%
    Check dated 2026-10-19T16:51:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T17:08:20.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, rendering the study record inaccessible. The usual study details and documents are no longer visible on the page.
    Difference
    20%
    Check dated 2026-09-21T20:44:29.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a small update to the site template rather than changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-31T18:18:50.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new NIH grant/contract annotation '2014 ( U.S. NIH Grant/Contract )' was added to the study's Other Study ID Numbers, documenting the funding source in the study record.
    Difference
    0.0%
    Check dated 2026-08-24T19:07:46.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.6.4 to v3.6.5 on the page, indicating an updated build/version of the record.
    Difference
    0.0%
    Check dated 2026-08-10T12:44:15.000Z thumbnail image

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.